896756008: Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\...
• \Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Product manufactured as parenteral dose form (product)\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Trastuzumab emtansine 100 mg powder for solution for infusion vial

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4029091014	Trastuzumab emtansine 100 mg powder for solution for infusion vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4029092019	Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start